These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 21691773)

  • 1. Integrative computational biology for cancer research.
    Fortney K; Jurisica I
    Hum Genet; 2011 Oct; 130(4):465-81. PubMed ID: 21691773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications.
    Jimenez CR; Verheul HM
    Am Soc Clin Oncol Educ Book; 2014; ():e504-10. PubMed ID: 24857147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New cancer biomarkers deriving from NCI early detection research.
    Verma M; Srivastava S
    Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-specific multi-omics models and the application in personalized combination therapy.
    John A; Qin B; Kalari KR; Wang L; Yu J
    Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions.
    Tolios A; De Las Rivas J; Hovig E; Trouillas P; Scorilas A; Mohr T
    Drug Resist Updat; 2020 Jan; 48():100662. PubMed ID: 31927437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation sequencing in the clinic: promises and challenges.
    Xuan J; Yu Y; Qing T; Guo L; Shi L
    Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer cell metabolism as new targets for novel designed therapies.
    Marín de Mas I; Aguilar E; Jayaraman A; Polat IH; Martín-Bernabé A; Bharat R; Foguet C; Milà E; Papp B; Centelles JJ; Cascante M
    Future Med Chem; 2014; 6(16):1791-810. PubMed ID: 25574531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of Immune Oncology: Challenges and Opportunities.
    Cesano A; Marincola FM; Thurin M
    Methods Mol Biol; 2020; 2055():3-21. PubMed ID: 31502145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preface on application of omics technologies in cancer biology and therapy.
    Georgakilas AG
    Cancer Lett; 2016 Nov; 382(1):A1. PubMed ID: 27765153
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic and Predictive Biomarkers in Cancer.
    Nair M; Sandhu SS; Sharma AK
    Curr Cancer Drug Targets; 2014; 14(5):477-504. PubMed ID: 24807144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of bioinformatics prediction in microRNA-based cancer therapeutics.
    Banwait JK; Bastola DR
    Adv Drug Deliv Rev; 2015 Jan; 81():94-103. PubMed ID: 25450261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of systems biology in cancer immunotherapy: from target discovery to biomarkers of clinical outcome.
    Guhathakurta D; Sheikh NA; Meagher TC; Letarte S; Trager JB
    Expert Rev Clin Pharmacol; 2013 Jul; 6(4):387-401. PubMed ID: 23927667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multitude of molecular analyses in cancer: the opening of Pandora’s box.
    Russnes HG; Lønning PE; Børresen-Dale AL; Lingjærde OC
    Genome Biol; 2014; 15(9):447. PubMed ID: 25316146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network science in clinical trials: A patient-centered approach.
    Manem VSK; Salgado R; Aftimos P; Sotiriou C; Haibe-Kains B
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):135-150. PubMed ID: 29278737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008).
    Aebersold R; Auffray C; Baney E; Barillot E; Brazma A; Brett C; Brunak S; Butte A; Califano A; Celis J; Cufer T; Ferrell J; Galas D; Gallahan D; Gatenby R; Goldbeter A; Hace N; Henney A; Hood L; Iyengar R; Jackson V; Kallioniemi O; Klingmüller U; Kolar P; Kolch W; Kyriakopoulou C; Laplace F; Lehrach H; Marcus F; Matrisian L; Nolan G; Pelkmans L; Potti A; Sander C; Seljak M; Singer D; Sorger P; Stunnenberg H; Superti-Furga G; Uhlen M; Vidal M; Weinstein J; Wigle D; Williams M; Wolkenhauer O; Zhivotovsky B; Zinovyev A; Zupan B
    Mol Oncol; 2009 Feb; 3(1):9-17. PubMed ID: 19383362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted therapy in cancer.
    Tsimberidou AM
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional profiling methods in cancer.
    Dopazo J
    Methods Mol Biol; 2010; 576():363-74. PubMed ID: 19882272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pursuit of Therapeutic Biomarkers with High-Throughput Cancer Cell Drug Screens.
    Williams SP; McDermott U
    Cell Chem Biol; 2017 Sep; 24(9):1066-1074. PubMed ID: 28736238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs and complex diseases: from experimental results to computational models.
    Chen X; Xie D; Zhao Q; You ZH
    Brief Bioinform; 2019 Mar; 20(2):515-539. PubMed ID: 29045685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.